Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazones. 1992

J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.

Mannich bases were synthesized and converted to the corresponding arylhydrazones. X-ray analysis of a ketone (1a) and a hydrazone (4d) revealed structural features of interest. All of the compounds showed cytotoxicity toward murine lymphocytic leukemia L1210 cells in the 4.9-25.0-microM range. The correlation coefficients generated by plotting the IC50 values (the concentrations of compounds that inhibit the growth of tumors by 50%) of some hydrazones against certain electronic, hydrophobic, and steric constants of the aryl substituents indicated only weak correlations. A few ketones and hydrazones displayed significant cytotoxicity to the WiDr human colon cancer cells, and these derivatives, especially the ketones, may serve as prototypes for future drug development. The KB tumor (a human epidermoid carcinoma of the nasopharynx) was somewhat refractory to selected compounds. In an in vitro assay conducted by the National Cancer Institute and involving approximately 53 tumor cell lines originating from eight neoplastic diseases, 65% of the compounds showed some selectivity toward one or more groups of cancers, principally leukemia, melanoma, and colon cancer. The bioevaluation of the ketones and hydrazones against the L1210, WiDr, and KB tumors, as well as evidence from proton nuclear magnetic resonance studies did not support the suggestion that hydrazones may be prodrugs of the corresponding ketones.

UI MeSH Term Description Entries
D007624 KB Cells This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. HeLa-KB Cells,Cell, HeLa-KB,Cell, KB,Cells, HeLa-KB,Cells, KB,HeLa KB Cells,HeLa-KB Cell,KB Cell
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008352 Mannich Bases Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols. Mannich Base,Base, Mannich,Bases, Mannich
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
May 1992, Journal of pharmaceutical sciences,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
July 1991, Die Pharmazie,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
January 2006, Arzneimittel-Forschung,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
October 1995, Die Pharmazie,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
March 1997, Die Pharmazie,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
January 2004, Arzneimittel-Forschung,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
January 2011, Arzneimittel-Forschung,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
January 2002, Arzneimittel-Forschung,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
August 2003, Journal of enzyme inhibition and medicinal chemistry,
J R Dimmock, and K M Advikolanu, and H E Scott, and M J Duffy, and R S Reid, and J W Quail, and Z Jia, and R A Hickie, and T M Allen, and J M Rutledge
January 2002, Arzneimittel-Forschung,
Copied contents to your clipboard!